摘要
目前肿瘤的抗血管生成治疗已成为肿瘤研究的热点及肿瘤治疗的新策略。本文就肿瘤抗血管治疗的基本理论、常用抗血管生成抑制剂的种类、以及目前的应用进展作一综述。
出处
《国外医学(免疫学分册)》
CAS
2004年第3期171-174,共4页
Foreign Medical Sciences(Section of Immunology Foreign Medical Sciences)
二级参考文献9
-
1Fukushima. Y, Oshika. Y, Tsuchda. T, et al. Brain-specific angiogenesis inhibitor 1 expression is inversely correlated with vascularity and distant metastasis of colorectal cancer. Int J Oncol. 1998 Nov; 13(5);967~70
-
2Lee. JH, Koh. JT, Shin. BA et al Comparative study of angiostatic and anti-invasive gene expressions as prognostic factors in gastric cancer Int J Oncol. 2001 Feb, 18(2):355~61
-
3Fan YF,Huang ZH. The study progress of gene therapy in colorectal cancers. Shijie Huaren Xiaohua Zazhi 2001;9:427~430
-
4Zhang ZS,Zhang YL. The study progress of colorectal cancers in china.Shijie Huaren Xiaohua Zazhi 2001;9:489 ~494
-
5Qu X,Liu JP,Qu H,Su HX. The expression of C-erbB-2 and EGFR in colorectal cancers. Shijie Huaren Xiaohua Zazhi 2001;9:838~839
-
6Qu X, Chen J, Lin TH. The prevention of human colorectal cancer LST174 BY monoclonal antibody to the epidermal growth factor receptor. Shijie Huaren Xiaohua Zazhi 2001;9:841
-
7Nishimoli. H, Shiratsuchi. T, Urano. T et al. A novel brain-specific p53 - target gene, BAI1, containing thrombospondin type 1 repeats inhibits experimental angiogenesis. Oncogene. 1997 Oct, 15(18):2145~50
-
8Yoshida. Y, Oshika. Y, Fukushima. Y, etal. Expression of anggiostatic factors in colorectal canncer. Int J Oncol. 1999 Dec;15(6):1221~5
-
9Natanaka. H, Oshika. Y, Abe. Y, et al. Vascularization is decreased in pulmonary adenocarcinoma expressing brain-specific angiogenesis inhibitor 1(BAI1). Int J Mol Med. 2000 Feb;5(2):181~3
共引文献3
-
1王培龙,张效通,张杨,段建敏,卢建中,巩进伟.脑组织特异性血管生成抑制因子1(BAI1)在肾癌中的表达及临床相关性研究[J].世界科技研究与发展,2015,37(4):374-376.
-
2刘芳,部晶,张鹏,安亚伟,尚雪飞,彭燕,成志勇.结直肠异常隐窝灶中BAI1、VEGF蛋白表达及意义[J].临床与实验病理学杂志,2016,32(8):856-859. 被引量:2
-
3梁跃,李光学,马庆庆.结直肠癌KRAS、NRAS、PIK3CA、BRAF基因联合突变分析及临床意义[J].中国社区医师,2018,34(14):107-109. 被引量:5
同被引文献11
-
1邹艳丽,孙谧,王跃军.海洋微生物溶菌酶的纯化与性质研究[J].生物工程学报,2005,21(3):420-424. 被引量:26
-
2Majno G, Jofis I. Apoptosis, oncosis and necrosis: An overview of cell death[J]. Am J Pathol, 1995,146:3- 15.
-
3Folkman J, Tumorangiogenesis : therapeutic implication [ J ]. New Engl J Med,1971,285(21) :1182- 1186.
-
4Marx J. Angiogenesis: A boost for tumor starvation [ J]. Science,2003,301:452 - 454.
-
5Huang X, Wong M K, Yi H, et al. Combined therapy of local and metastatic 4TI breast tumor in mice using SU6668 and the immunostimulator B7.2-1gG fusion protein [J]. Cancer Res,2002,62(20) :5727 - 5735.
-
6Vicki B. Endostatin cell factories shrink rodent brain tumors [ J ]. Trendsin Molecular Medicine, 2001,7 ( 3 ) : 97 - 98.
-
7Faulkner D J. Highlights of marine natural products chemistry( 1972 - 1999) [J]. Nat Prod Rep ,2000, 17( 1 ) : 1 -6.
-
8Shu Y Z. Recent natural products based drug development: A pharmaceutical industry perspective [ J ]. J Nat Prod, 1998,61 (8) : 1053 - 1071 .
-
9刘同军,徐文琳,张玉臻.变溶菌素(Mutanolysin)研究历史和发展前景[J].微生物学报,2000,40(2):224-227. 被引量:16
-
10王跃军,孙谧,张云波,洪义国,郝建华,刘晓萍,王春波.海洋低温溶菌酶的制备及酶学性质[J].海洋水产研究,2000,21(4):54-63. 被引量:27
-
1曾艳平,戈伟.放疗联合抗血管疗法在肿瘤治疗中的研究进展[J].微循环学杂志,2008,18(4):49-51. 被引量:6
-
2郑君议,陈建斌.恶性血液病抗血管生成治疗的研究进展[J].国外医学(输血及血液学分册),2005,28(6):523-526.
-
3董美钰,齐湘杰,畅继武.肾癌的基因治疗进展[J].国外医学(泌尿系统分册),2004,24(3):366-369. 被引量:1
-
4王成伟.癌症治疗新策略——抗血管生成疗法[J].抗癌,2001(1):37-37.
-
5李敏,钱晓萍,刘宝瑞.肿瘤抗血管生成治疗临床应用进展[J].江苏医药,2007,33(2):194-195.
-
6罗海水,王强,卞修武.抗血管生成抑制剂疗法研究进展[J].医学信息(医学与计算机应用),2001,14(1):57-58.
-
7张江宇,王颀,尹爱华,陈文静,赖日权,张佳立.CD105在乳腺微浸润和浸润性导管癌表达的研究[J].中国实用医药,2008,3(3):10-11.
-
8张其亮,杨述华.VEGF及其受体在肿瘤抗血管治疗中的应用[J].国外医学(生理病理科学与临床分册),2003,23(3):248-250. 被引量:4
-
9常卫华,赵治国.血管内皮抑素的研究进展[J].肿瘤基础与临床,2007,20(1):82-85. 被引量:3
-
10肝细胞癌的缺氧状态[J].传染病网络动态,2008(1):19-19.